TACSTD2 and cancer: In a sub-group of patients with muscle-invasive tumors (n = 62), high Trop-2 expression was also associated with favorable PFS (p = 0.032, Supplementary Figure S1A) and cancer-specific survival (p = 0.061, Supplementary Figure S1B).